lovastatin has been researched along with Benign Psychomotor Epilepsy, Childhood in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdanipour, A; Anarkooli, IJ; Ganjkhani, M; Moradi, P | 1 |
| Chen, IC; Jaw, T; Lee, CY; Liou, HH; Tseng, HC | 1 |
2 other study(ies) available for lovastatin and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
Neuroprotective effects of lovastatin in the pilocarpine rat model of epilepsy according to the expression of neurotrophic factors.
Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Ciliary Neurotrophic Factor; Disease Models, Animal; Epilepsy, Temporal Lobe; Glial Cell Line-Derived Neurotrophic Factor; Hippocampus; Lovastatin; Male; Nerve Growth Factors; Neurons; Neuroprotective Agents; Neurotrophin 3; Pilocarpine; Rats; Rats, Wistar | 2019 |
Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus.
Topics: Animals; Anticholesteremic Agents; Blotting, Western; Dentate Gyrus; Disease Models, Animal; Electrophysiology; Epilepsy, Temporal Lobe; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Intercellular Signaling Peptides and Proteins; Lovastatin; Male; Mossy Fibers, Hippocampal; Muscarinic Agonists; Nerve Tissue Proteins; Pilocarpine; Rats; Rats, Wistar; Seizures; Status Epilepticus | 2012 |